At-Risk Diabetes Patients Could Get Drug Before January

The Food and Drug Administration’s potential breakthrough drug for diabetes – which has the capacity to delay the onset of Type 1 diabetes — could be ready for high-risk patients before January.According to The New York Times, Tzield (or teplizumab) became the result of an…

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.